Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Massimo Girardis and Roberto D'Amico.
Massimo Girardis
Connection Strength
0.989
Roberto D'Amico
  1. The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study. PLoS One. 2021; 16(8):e0251378.
    View in: PubMed
    Score: 0.240
  2. Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1141.
    View in: PubMed
    Score: 0.233
  3. Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial). BMJ Open. 2021 02 11; 11(2):e036616.
    View in: PubMed
    Score: 0.232
  4. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Aug 17; 21(1):724.
    View in: PubMed
    Score: 0.224
  5. Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study. Pulmonology. 2021 Mar 22.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.